Effect of antibiotic use on the efficacy of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer: A meta-analysis
This study evaluates the impact of the use of antibiotics on the effectiveness of nivolumab in the treatment of advanced/metastatic non-small cell lung cancer (NSCLC). A literature search was conducted in various electronic databases to identify studies, which evaluated the impact of antibiotic use...
Main Authors: | Huo Geng-wei, Zuo Ran, Song Ying, Chen Wei-dong, Chen Wen-ming, Chong Dao-qun, Zhang Hong-mei, Jia Sha-sha, Chen Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-05-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2021-0272 |
Similar Items
-
Broad-Spectrum Antibiotic Regimen Affects Survival in Patients Receiving Nivolumab for Non-Small Cell Lung Cancer
by: Min Jung Geum, et al.
Published: (2021-05-01) -
Bilateral uveitis associated with nivolumab therapy for metastatic non-small cell lung cancer
by: Christopher R. Dermarkarian, MD, et al.
Published: (2020-06-01) -
Time-Dependent Efficacy of Checkpoint Inhibitor Nivolumab: Results from a Pilot Study in Patients with Metastatic Non-Small-Cell Lung Cancer
by: Abdoulaye Karaboué, et al.
Published: (2022-02-01) -
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer
by: Walid Shalata, et al.
Published: (2023-08-01) -
The benefit and risk of nivolumab in non‐small‐cell lung cancer: a single‐arm meta‐analysis of noncomparative clinical studies and randomized controlled trials
by: Binghao Zhao, et al.
Published: (2018-05-01)